Table 3.
mir-202 Function | Regulation | Samples, Cell Lines, Patient Material, Animal Model | Involved Downstream/Upstream Molecules | References |
---|---|---|---|---|
suppressor | down | 56 patient tissues and corresponding normal tissues, cell lines | STAT3 | [46] |
suppressor | down | 40 lung adenocarcinoma and adjacent normal tissue samples | KCNK15-AS1, EGFR, miR-202/miR-370/EGFR axis | [48] |
suppressor | down | 40 NSCLC tissues, cell lines | MALAT1 | [49] |
suppressor | down | 25 NSCLC and adjacent paratumor tissues, cell lines, mouse xenografts | KRAS | [47] |
suppressor | down | cell lines | NORAD | [50] |
suppressor | down | 20 lung cancer and adjacent normal tissues | cyclin D1 | [45] |
suppressor | down | 26 tumor and corresponding normal lung tissue samples | n.d. | [44] |
suppressor | down | Nude mice, cell lines | [34] | |
pro-tumorigenic | up | 125 plasma samples first-line chemotherapy | Macrophage Polarization | [8] |
n.d. = no data.